Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2006 of 5804
-
New study tests better ways to fix dangerous aortic bulges
Disease control Recruiting nowThe aim of this randomized study is to compare the safety and performance of EndoVascular Aneurysm Repair with ESAR using Endurant + Heli-FX™ EndoAnchor™ system and FEVAR using customizable grafts from Cook (Zenith Fenestrated Graft) and Terumo (Fenestrated Anaconda Graft) for th…
Phase: NA • Sponsor: FCRE (Foundation for Cardiovascular Research and Education) • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for kids with tough leukemia: experimental combo tested
Disease control CompletedThis phase I trial studies the best dose and side effects of liposomal cytarabine, daunorubicin, and gemtuzumab ozogamicin in treating pediatric patients with acute myeloid leukemia that has returned after treatment (relapsed) or does not respond to treatment (refractory). Chemot…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug could protect children with cancer from chemo side effects
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma and treated with myelosuppressive chemotherapy.
Phase: PHASE2 • Sponsor: Spectrum Pharmaceuticals, Inc • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Heated chemo during second surgery shows promise for ovarian cancer
Disease control CompletedThe purpose of this research study is to see if it is feasible to receive heated chemotherapy or heated intraperitoneal chemotherapy (HIPEC) inserted directly into the abdomen at the time of a Second Look Reassessment Surgery and to monitor any effects good or bad that this has o…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a common blood pressure pill boost immunotherapy for bladder cancer?
Disease control OngoingThis research study is an open label study designed to evaluate the safety and translational correlative changes of the combination of propranolol hydrochloride and immune checkpoint inhibitors (ICI) in subjects with urothelial carcinoma.
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Mind over pain: new study tests Brain-Based therapy for back pain
Symptom relief Recruiting nowThe goal of this study is to determine if a mind-body intervention can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of a mind body intervention in reducing disability from back pain and alleviating ba…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Knee pain relief: which PRP injection works best?
Symptom relief CompletedThe aim of our study is to determine the effects of intra-articular Platelet-Rich Plasma (PRP) prepared with two different techniques on pain intensity, functional status, quality of life, functional balance and femoral cartilage thickness in patients with knee osteoarthritis.
Phase: NA • Sponsor: Istanbul University • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Tailored chemo dosing aims to boost stem cell transplant success in myeloma
Disease control Recruiting nowThis phase I trial studies the best dose and side effects of mephalan in treating patients with multiple myeloma who are undergoing stem cell transplant. Chemotherapy drugs, such as mephalan, work in different ways to stop the growth of cancer cells, either by killing the cells, …
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Wearable tech and home visits aim to ease the burden on dementia caregivers
Symptom relief CompletedThe proposed study will test a 3-month, community health worker (CHW) delivered home visit, culturally and language-appropriate intervention for ethnic and underserved dementia family caregivers of persons with dementia (PWD) using wearable technology for real time monitoring of …
Phase: NA • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Brain oxygen watch during heart surgery may shield memory
Knowledge-focused CompletedNeurological dysfunction continues to be one of the complications of considerable concern in patients undergoing cardiac surgery. It was previously reported in the literature, that cerebral oxygen desaturation during cardiac surgery was associated with an increased incidence of c…
Phase: NA • Sponsor: Instituto Nacional de Cardiologia de Laranjeiras • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New pill aims to calm schizophrenia symptoms fast
Symptom relief CompletedThe purpose of this study is to determine the efficacy, safety, tolerability and pharmacokinetics (PK) properties of CPL500036 compound (PDE10a inhibitor) in patients with an acute exacerbation of schizophrenia after 28 days of administration..
Phase: PHASE2 • Sponsor: Celon Pharma SA • Aim: Symptom relief
Last updated Jun 26, 2026 16:11 UTC
-
Chocolate and pills: could they keep seniors on their feet?
Disease control OngoingThe COcoa Supplement and Multivitamin Outcomes Study (COSMOS; NCT02422745) is a randomized clinical trial of cocoa extract supplement (containing a total of 500 mg/d flavanols, including 80 mg. (-)-epicatechins), and a standard multivitamin supplement to reduce the risk of cardio…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
ALS study aims to uncover hidden nerve damage clues
Knowledge-focused Recruiting nowThe goal of this interventional non-pharmacological study is to evaluate, using a multimodal approach, the progression of autonomic and sensory involvement in in amyotrophic lateral sclerosis (ALS) patients enrolled within 18 months from motor onset and its relationship with the …
Phase: NA • Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Brain training may delay dementia in At-Risk seniors
Disease control OngoingBackground: Dementia is a debilitating and devastating disease impacting the individuals, their families, and the health care system. According to the World Health Organization the dementia epidemic could overwhelm the global health care system and undermine social and economic …
Phase: NA • Sponsor: Sorlandet Hospital HF • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New hope for nail psoriasis: tildrakizumab shows promise in trial
Symptom relief CompletedPhase 3b study to Assess the Efficacy and Safety of Tildrakizumab in the Treatment of Moderate to Severe Nail Psoriasis
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Brain & hormones: why women face rising alcohol risks
Knowledge-focused Recruiting nowThe sex gap in alcohol consumption is closing rapidly, due to alarming increases among women. From 2002-2013, Alcohol Use Disorder (AUD) increased 84% for women, compared to 35% for men. As such, there is an urgent need to determine the factors underlying sex differences in risk …
Phase: NA • Sponsor: Jessica Weafer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Tiny particles in blood may reveal how well breast cancer chemo works
Diagnosis Recruiting nowExtracellular vesicles (EVs) are lipid bilayer-delimited particles, naturally released from the cells and mediators of intercellular cross-talk. In breast cancer (BC), EVs seem to be involved in the tumor microenvironment's shaping, in cancer cells invasion and in the set-up of m…
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
Could a common mushroom help fight prostate cancer?
Disease control TerminatedThis phase II trial studies how well white button mushroom supplement works in reducing prostate-specific antigen (PSA) levels in patients with prostate cancer that has come back (recurrent) or has favorable risk and has not undergone any therapy (therapy naive). PSA is a blood m…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a simple ultrasound replace CT scans for kids with belly injuries?
Diagnosis CompletedThis multicenter study aims to evaluate the accuracy of contrast-enhanced ultrasound (CEUS) in diagnosing abdominal solid organ injuries in pediatric patients. Up to 130 subjects will complete the study across approximately 5-10 sites in the US, with up to 30 patients in the trai…
Phase: PHASE1, PHASE2 • Sponsor: David Mooney • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
20,000 cancer patients to get genetic profiling in hunt for new treatments
Knowledge-focused Recruiting nowThe objective of STING study is to perform high throughput molecular analysis (next generation sequencing +/- immunological profiling) to estimate the proportion of patients with cancer presenting at least one targetable genomic alteration.
Phase: NA • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC